Quantcast

Latest biopharmaceutical Stories

2014-01-13 12:28:06

LAUSANNE, Switzerland, January 13, 2014 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, announces that it has completed the recruitment of patients for its Phase III clinical study in Central Precocious Puberty (CPP) with triptorelin 22.5 mg. Debiopharm is investigating the efficacy and safety of...

2014-01-10 12:25:31

DUBLIN, Jan. 10, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/qhnxt9/biotechnology) has announced the addition of the "2013 Report on the International Biotechnology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2017" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The biotechnology market is primarily driven by the regulatory support provided by governments of various countries,...

2014-01-08 08:28:09

HOERSHOLM, Denmark, and SAN DIEGO, Jan. 8, 2014 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has hired J. Donald deBethizy, PhD as President and Chief Executive Officer (CEO), effective January 1, 2014. (Logo: http://photos.prnewswire.com/prnh/20100111/SPLOGO) Dr. deBethizy brings more than 20 years of experience in managing and financing life science...

2014-01-08 00:21:38

COPENHAGEN, Denmark and SEATTLE, Jan. 7, 2014 /PRNewswire/ -- CMC Biologics, a leading biopharmaceutical process development and biopharmaceutical manufacturing organization, announced today that it has appointed Jesper Bramming as Chief Financial Officer (CFO) of its global operations. (Logo: http://photos.prnewswire.com/prnh/20110502/SF93356LOGO) Jesper Bramming brings more than 25 years of financial and management experience to CMC Biologics' Executive Management Team,...

2014-01-07 08:31:00

Lam Joins KaloBios with Over 28 Years Biopharmaceutical Manufacturing Experience SOUTH SAN FRANCISCO, Calif., Jan. 7, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the appointment of Harry Lam, Ph.D. as Head of Manufacturing. Dr. Lam brings to KaloBios more than 28 years of experience in biopharmaceutical manufacturing, including 17 years at Genentech, where he ultimately served as Global Head of Contract Manufacturing Operations, Commercial Drug...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related